Batteries not included: Diagnosis and management of mitochondrial disease

Journal of Internal Medicine

Volumn 265, Issue 2, 2009, Pages 210-228

  McFarland, R ^a   Turnbull, D M ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Mitochondrial disease; Neurogenetics; Respiratory chain disorders

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOCHROME C OXIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MITOCHONDRIAL DNA;

CARDIOMYOPATHY; CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA STRUCTURE; ENZYME ACTIVITY; GENE MUTATION; HEART MUSCLE CONDUCTION DISTURBANCE; HETEROPLASMY; HOMOPLASY; HUMAN; KEARNS SAYRE SYNDROME; LACTIC ACIDOSIS; LEBER CONGENITAL AMAUROSIS; LEIGH DISEASE; MATERNALLY INHERITED DIABETES AND DEAFNESS; MELAS SYNDROME; MERRF SYNDROME; MITOCHONDRIAL DNA DEPLETION SYNDROME; MITOCHONDRIAL ENCEPHALOPATHY; MITOCHONDRIAL GENETICS; MITOCHONDRIAL MYOPATHY; MITOCHONDRIAL RESPIRATION; MNGIE SYNDROME; MOLECULAR GENETICS; MUSCLE BIOPSY; MUTATIONAL ANALYSIS; NEUROPATHY ATAXIA RETINITIS PIGMENTOSA; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PEARSON SYNDROME; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RADIODIAGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SOUTHERN BLOTTING; STROKE; TISSUE SPECIFICITY;

DNA, MITOCHONDRIAL; GENE DELETION; HUMANS; MITOCHONDRIAL DISEASES; OXIDATIVE PHOSPHORYLATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 58149328514     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2008.02066.x     Document Type: Conference Paper

References (121)

1. Margulis L. Genetic and evolutionary consequences of symbiosis. Exp Parasitol 1976 39 : 277 349.
2. Lister R, Hulett JM, Lithgow T, Whelan J. Protein import into mitochondria: origins and functions today. Mol Membr Biol 2005 22 : 87 100 (Review).
3. Gabaldon T, Huynen MA. Shaping the mitochondrial proteome. Biochim Biophys Acta 2004 1659 : 212 20.
4. Margineantu DH, Gregory Cox W, Sundell L, Sherwood SW, Beechem JM, Capaldi RA. Cell cycle dependent morphology changes and associated mitochondrial DNA redistribution in mitochondria of human cell lines. Mitochondrion 2002 1 : 425 35.
5. Hudson G, Amati-Bonneau P, Blakely EL et al. Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance. Brain 2008 131 : 329 37.
6. Anderson S, Bankier AT, Barrell BG et al. Sequence and organization of the human mitochondrial genome. Nature 1981 290 : 457 65.
7. Andrews RM, Kubacka I, Chinnery PF, Turnbull DM, Lightowlers RN, Howell N. Reanalysis and revision of the Cambridge Reference Sequence. Nat Genet 1999 23 : 147.
8. Schwartz M, Vissing J. Paternal inheritance of mitochondrial DNA. N Engl J Med 2002 347 : 576 80.
9. Taylor RW, Giordano C, Davidson MM et al. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy. J Am Coll Cardiol 2003 41 : 1786 96.
10. Filosto M, Mancuso M, Vives-Bauza C et al. Lack of paternal inheritance of muscle mitochondrial DNA in sporadic mitochondrial myopathies. Ann Neurol 2003 54 : 524 6.
11. Lightowlers RN, Chinnery PF, Turnbull DM, Howell N. Mammalian mitochondrial genetics: heredity, heteroplasmy and disease. Trends Genet 1997 13 : 450 5.
12. DiMauro S, Schon EA. Mitochondrial DNA mutations in human disease. Am J Med Genet 2001 106 : 18 26.
13. Wallace DC, Singh G, Lott MT et al. Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy. Science 1988 242 : 1427 30.
14. Rahman S, Poulton J, Marchington D, Suomalainen A. Decrease of 3243 A - >G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 2001 68 : 238 40.
15. Battersby BJ, Loredo-Osti JC, Shoubridge EA. Nuclear genetic control of mitochondrial DNA segregation. Nat Genet 2003 33 : 183 6.
16. McFarland R, Taylor RW, Turnbull DM. The neurology of mitochondrial DNA disease. Lancet Neurol 2002 1 : 343 51.
17. Taylor RW, Schaefer AM, Barron MJ, McFarland R, Turnbull DM. The diagnosis of mitochondrial muscle disease. Neuromuscul Disord 2004 14 : 237 45.
18. Chinnery PF, Johnson MA, Wardell TM et al. The epidemiology of pathogenic mitochondrial DNA mutations. Ann Neurol 2000 48 : 188 93.
19. Mackey DA, Buttery RG. Leber hereditary optic neuropathy in Australia. Aust N Z J Ophthalmol 1992 20 : 177 84.
20. Man PY, Griffiths PG, Brown DT, Howell N, Turnbull DM, Chinnery PF. The epidemiology of Leber hereditary optic neuropathy in the North East of England. Am J Hum Genet 2003 72 : 333 9.
21. Hudson G, Keers S, Yu Wai Man P et al. Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder. Am J Hum Genet 2005 77 : 1086 91.
22. Gerbitz K-D, van den Ouweland JMW, Maasen JA, Jaksch M. Mitochondrial diabetes: a review. Biochim Biophys Acta 1995 1271 : 253 60.
23. Majamaa K, Moilanen JS, Uimonen S et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998 63 : 447 54.
24. Manwaring N, Jones MM, Wang JJ et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007 7 : 230 3.
25. Schaefer AM, McFarland R, Blakely EL et al. Prevalence of mitochondrial DNA disease in adults. Ann Neurol 2008 63 : 35 9.
26. Uusimaa J, Remes AM, Rantala H et al. Childhood encephalopathies and myopathies: a prospective sudy in a defined population to assess the frequency of mitochondrial diseases. Pediatrics 2000 105 : 598 603.
27. Skladal D, Halliday J, Thorburn DR. Minimum birth prevalence of mitochondrial respiratory chain disorders in children. Brain 2003 126 : 1905 12.
28. McFarland R, Kirby DM, Fowler KJ et al. De novo mutations in the mitochondrial ND3 gene as a cause of infantile mitochondrial encephalopathy and complex I deficiency. Ann Neurol 2004 55 : 58 64.
29. Kirby DM, McFarland R, Ohtake A et al. Mutations of the mitochondrial ND1 gene as a cause of MELAS. J Med Genet 2004 41 : 784 9.
30. Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet 2005 6 : 389 402.
31. Griggs RC, Karpati G. Muscle pain, fatigue, and mitochondriopathies. N Engl J Med 1999 341 : 1077 8.
32. Bernier FP, Boneh A, Dennett X, Chow CW, Cleary MA, Thorburn DR. Diagnostic criteria for respiratory chain disorders in adults and children. Neurology 2002 59 : 1406 11.
33. Bourdon A, Minai L, Serre V et al. Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion. Nat Genet 2007 39 : 776 80.
34. de Lonlay P, Valnot I, Barrientos A et al. A mutant mitochondrial respiratory chain assembly protein causes complex III deficiency in patients with tubulopathy, encephalopathy and liver failure. Nat Genet 2001 29 : 57 60.
35. De Meirleir L, Seneca S, Damis E et al. Clinical and diagnostic characteristics of complex III deficiency due to mutations in the BCS1L gene. Am J Med Genet A 2003 121 : 126 31.
36. Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA. Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 1995 118 : 339 57.
37. Zhu Z, Yao J, Johns T et al. SURF1, encoding a factor involved in the biogenesis of cytochrome c oxidase, is mutated in Leigh syndrome. Nat Genet 1998 20 : 337 43.
38. McFarland R, Clark KM, Morris AA et al. Multiple neonatal deaths due to a homoplasmic mitochondrial DNA mutation. Nat Genet 2002 30 : 145 6.
39. Brierley EJ, Johnson MA, Lightowlers RN, James OF, Turnbull DM. Role of mitochondrial DNA mutations in human aging: implications for the central nervous system and muscle. Ann Neurol 1998 43 : 217 23.
40. Schagger H, von Jagow G. Blue native electrophoresis for isolation of membrane protein complexes in enzymatically active form. Anal Biochem 1991 199 : 223 31.
41. Wittig I, Karas M, Schagger H. High resolution clear native electrophoresis for in-gel functional assays and fluorescence studies of membrane protein complexes. Mol Cell Proteomics 2007 6 : 1215 25.
42. Wittig I, Carrozzo R, Santorelli FM, Schagger H. Functional assays in high-resolution clear native gels to quantify mitochondrial complexes in human biopsies and cell lines. Electrophoresis 2007 28 : 3811 20.
43. Loeffen JL, Smeitink JA, Trijbels JM et al. Isolated complex I deficiency in children: clinical, biochemical and genetic aspects. Hum Mutat 2000 15 : 123 34.
44. Oldfors A, Holme E, Tulinius M, Larsson NG. Tissue distribution and disease manifestations of the tRNA(Lys) A - >G(8344) mitochondrial DNA mutation in a case of myoclonus epilepsy and ragged red fibres. Acta Neuropathol 1995 90 : 328 33.
45. Morten KJ, Ashley N, Wijburg F et al. Liver mtDNA content increases during development: a comparison of methods and the importance of age- and tissue-specific controls for the diagnosis of mtDNA depletion. Mitochondrion 2007 7 : 386 95.
46. He L, Chinnery PF, Durham SE et al. Detection and quantification of mitochondrial DNA deletions in individual cells by real-time PCR. Nucleic Acids Res 2002 30 : e68.
47. MITOMAP. 2008. A Human Mitochondrial Genome Database. http://www.mitomap.org, accessed on 27 October 2008.
48. McFarland R, Elson JL, Taylor RW, Howell N, Turnbull DM. Assigning pathogenicity to mitochondrial tRNA mutations: when "definitely maybe" is not good enough. Trends Genet 2004 20 : 591 6.
49. van Den Bosch BJ, de Coo RF, Scholte HR et al. Mutation analysis of the entire mitochondrial genome using denaturing high performance liquid chromatography. Nucleic Acids Res 2000 28 : E89.
50. Biggin A, Henke R, Bennetts B, Thorburn DR, Christodoulou J. Mutation screening of the mitochondrial genome using denaturing high-performance liquid chromatography. Mol Genet Metab 2005 84 : 61 74.
51. McFarland R, Taylor RW, Chinnery PF, Howell N, Turnbull DM. A novel sporadic mutation in cytochrome c oxidase subunit II as a cause of rhabdomyolysis. Neuromuscul Disord 2004 14 : 162 6.
52. Saunier P, Chretien D, Wood C et al. Cytochrome c oxidase deficiency presenting as recurrent neonatal myoglobinuria. Neuromuscul Disord 1995 5 : 285 9.
53. Deschauer M, Wieser T, Neudecker S, Lindner A, Zierz S. Mitochondrial 3243 A - >G mutation (MELAS mutation) associated with painful muscle stiffness. Neuromuscul Disord 1999 9 : 305 7.
54. Sproule DM, Kaufmann P, Engelstad K, Starc TJ, Hordof AJ, De Vivo DC. Wolff-Parkinson-White syndrome in patients with MELAS. Arch Neurol 2007 64 : 1625 7.
55. Karanikis P, Korantzopoulos P, Kountouris E et al. Kearns-Sayre syndrome associated with trifascicular block and QT prolongation. Int J Cardiol 2005 101 : 147 50.
56. Subbiah RN, Kuchar D, Baron D. Torsades de pointes in a patient with Kearns-Sayre syndrome: a fortunate finding. Pacing Clin Electrophysiol 2007 30 : 137 9.
57. Welzing L, von Kleist-Retzow JC, Kribs A, Eifinger F, Huenseler C, Sreeram N. Rapid development of life-threatening complete atrioventricular block in Kearns-Sayre syndrome. Eur J Pediatr 2008 Sep 24 [EPub ahead of print].
58. Kleiner L, Sherman J. Leber's hereditary optic neuropathy: historical and contemporary considerations. Optom Clin 1996 5 : 77 112.
59. Huoponen K. Leber hereditary optic neuropathy: clinical and molecular genetic findings. Neurogenetics 2001 3 : 119 25.
60. Stone EM, Newman NJ, Miller NR, Johns DR, Lott MT, Wallace DC. Visual recovery in patients with Leber's hereditary optic neuropathy and the 11778 mutation. J Clin Neuroophthalmol 1992 12 : 10 4.
61. Harding AE, Riordan-Eva P, Govan GG. Mitochondrial DNA diseases: genotype and phenotype in Leber's hereditary optic neuropathy. Muscle Nerve 1995 3 : S82 4.
62. Jun AS, Brown MD, Wallace DC. A mitochondrial DNA mutation at nucleotide pair 14459 of the NADH dehydrogenase subunit 6 gene associated with maternally inherited Leber hereditary optic neuropathy and dystonia. Proc Natl Acad Sci USA 1994 91 : 6206 10.
63. Hammans SR, Sweeney MG, Hanna MG, Brockington M, Morgan-Hughes JA, Harding AE. The mitochondrial DNA transfer RNALeu(UUR) A - >G(3243) mutation. A clinical and genetic study. Brain 1995 118 : 721 34.
64. Rigoli L, Prisco F, Caruso RA et al. Association of the T14709C mutation of mitochondrial DNA with maternally inherited diabetes mellitus and/or deafness in an Italian family. Diabet Med 2001 18 : 334 6.
65. Sue CM, Tanji K, Hadjigeorgiou G et al. Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology 1999 52 : 1905 8.
66. Reid FM, Vernham GA, Jacobs HT. A novel mitochondrial point mutation in a maternal pedigree with sensorineural deafness. Hum Mutat 1994 3 : 243 7.
67. Tiranti V, Chariot P, Carella F et al. Maternally inherited hearing loss, ataxia and myoclonus associated with a novel point mutation in mitochondrial tRNASer(UCN) gene. Hum Mol Genet 1995 4 : 1421 7.
68. Ballinger SW, Shoffner JM, Hedaya EV et al. Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1992 1 : 11 5.
69. Zupanc ML, Moraes CT, Shanske S, Langman CB, Ciafaloni E, DiMauro S. Deletion of mitochondrial DNA in patients with combined features of Kearns-Sayre and MELAS syndromes. Ann Neurol 1991 29 : 680 3.
70. Amati-Bonneau P, Valentino ML, Reynier P et al. OPA1 mutations induce mitochondrial DNA instability and optic atrophy 'plus' phenotypes. Brain 2008 131 : 338 51.
71. Jin H, May M, Tranebjaerg L et al. A novel X-linked gene, DDP, shows mutations in families with deafness (DFN-1), dystonia, mental deficiency and blindness. Nat Genet 1996 14 : 177 80.
72. Prezant TR, Agapian JV, Bohlman MC et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 1993 4 : 289 94.
73. Guan MX, Fischel-Ghodsian N, Attardi G. Nuclear background determines biochemical phenotype in the deafness-associated mitochondrial 12S rRNA mutation. Hum Mol Genet 2001 10 : 573 80.
74. Bykhovskaya Y, Mengesha E, Wang D et al. Phenotype of non-syndromic deafness associated with the mitochondrial A1555G mutation is modulated by mitochondrial RNA modifying enzymes MTO1 and GTPBP3. Mol Genet Metab 2004 83 : 199 206.
75. Hutchin T, Haworth I, Higashi K et al. A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res 1993 21 : 4174 9.
76. Estivill X, Govea N, Barcelo A et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet 1998 62 : 27 35.
77. Hobbie SN, Bruell CM, Akshay S, Kalapala SK, Shcherbakov D, Bottger EC. Mitochondrial deafness alleles confer misreading of the genetic code. Proc Natl Acad Sci USA 2008 105 : 3244 9.
78. Nagashima T, Mori M, Katayama K et al. Adult Leigh syndrome with mitochondrial DNA mutation at 8993. Acta Neuropathol 1999 97 : 416 22.
79. Leigh D. Subacute necrotizing encephalomyelopathy in an infant. J Neurol Neurosurg Psychiatr 1951 14 : 216 21.
80. Rahman S, Blok RB, Dahl HH et al. Leigh syndrome: clinical features and biochemical and DNA abnormalities. Ann Neurol 1996 39 : 343 51.
81. De Braekeleer M. Genetic epidemiology of autosomal recessive spastic ataxia of Charlevoix-Saguenay in northeastern Quebec. Genet Epidemiol 1993 10 : 17 25.
82. Mootha VK, Lepage P, Miller K et al. Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics. Proc Natl Acad Sci USA 2003 100 : 605 10.
83. Huttenlocher PR, Solitare GB, Adams G. Infantile diffuse cerebral degeneration with hepatic cirrhosis. Arch Neurol 1976 33 : 186 92.
84. Saada A, Shaag A, Mandel H, Nevo Y, Eriksson S, Elpeleg O. Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy. Nat Genet 2001 29 : 342.
85. Mandel H, Szargel R, Labay V et al. The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA. Nat Genet 2001 29 : 337 41.
86. Naviaux RK, Nguyen KV. POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion. Ann Neurol 2004 55 : 706 12.
87. Spinazzola A, Viscomi C, Fernandez-Vizarra E et al. MPV17 encodes an inner mitochondrial membrane protein and is mutated in infantile hepatic mitochondrial DNA depletion. Nat Genet 2006 38 : 570 5.
88. Elpeleg O, Miller C, Hershkovitz E et al. Deficiency of the ADP-forming succinyl-CoA synthase activity is associated with encephalomyopathy and mitochondrial DNA depletion. Am J Hum Genet 2005 76 : 1081 6.
89. Ostergaard E, Christensen E, Kristensen E et al. Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet 2007 81 : 383 7.
90. Morikawa Y, Matsuura N, Kakudo K, Higuchi R, Koike M, Kobayashi Y. Pearson's marrow/pancreas syndrome: a histological and genetic study. Virchows Arch A Pathol Anat Histopathol 1993 423 : 227 31.
91. Zeviani M, Moraes CT, DiMauro S et al. Deletions of mitochondrial DNA in Kearns-Sayre syndrome. Neurology 1988 38 : 1339 46.
92. Poulton J, Morten KJ, Marchington D et al. Duplications of mitochondrial DNA in Kearns-Sayre syndrome. Muscle Nerve 1995 3 : S154 8.
93. Goto Y, Nonaka I, Horai S. A mutation in the tRNA(Leu)(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990 348 : 651 3.
94. LeuUUR in patients with the MELAS phenotype. Hum Mol Genet 1995 4 : 1689 91.
95. Sternberg D, Chatzoglou E, Laforet P et al. Mitochondrial DNA transfer RNA gene sequence variations in patients with mitochondrial disorders. Brain 2001 124 : 984 94.
96. Bataillard M, Chatzoglou E, Rumbach L et al. Atypical MELAS syndrome associated with a new mitochondrial tRNA glutamine point mutation. Neurology 2001 56 : 405 7.
97. de Coo IF, Sistermans EA, de Wijs IJ et al. A mitochondrial tRNA(Val) gene mutation (G1642A) in a patient with mitochondrial myopathy, lactic acidosis, and stroke-like episodes. Neurology 1998 50 : 293 5.
98. Liolitsa D, Rahman S, Benton S, Carr LJ, Hanna MG. Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations? Ann Neurol 2003 53 : 128 32.
99. Martinuzzi A, Bartolomei L, Carrozzo R et al. Correlation between clinical and molecular features in two MELAS families. J Neurol Sci 1992 113 : 222 9.
100. Damian MS, Seibel P, Reichmann H et al. Clinical spectrum of the MELAS mutation in a large pedigree. Acta Neurol Scand 1995 92 : 409 15.
101. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet 1992 1 : 368 71.
102. Walker M, Taylor RW, Turnbull DM. Mitochondrial diabetes. Diabet Med 2005 22 (Suppl. 4 18 20.
103. Maassen JA, LM TH, Van Essen E et al. Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 2004 53 (Suppl. 1 S103 9.
104. Vialettes BH, Paquis-Flucklinger V, Pelissier JF et al. Phenotypic expression of diabetes secondary to a T14709C mutation of mitochondrial DNA. Comparison with MIDD syndrome (A3243G mutation): a case report. Diabetes Care 1997 20 : 1731 7.
105. Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Diabetes and deafness: is it sufficient to screen for the mitochondrial 3243A>G mutation alone? Diabetes Care 2007 30 : 2238 9.
106. Whittaker RG, Schaefer AM, McFarland R, Taylor RW, Walker M, Turnbull DM. Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 2007 50 : 2085 9.
107. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet 1990 46 : 428 33.
108. Santorelli FM, Shanske S, Jain KD, Tick D, Schon EA, DiMauro S. A T - >C mutation at nt 8993 of mitochondrial DNA in a child with Leigh syndrome. Neurology 1994 44 : 972 4.
109. de Vries DD, van Engelen BGM, Gabreels FJM, Ruitenbeek W, van Oost BA. A second missense mutation in the mitochondrial ATPase 6 gene mutation in Leigh's syndrome. Ann Neurol 1993 34 : 410 2.
110. Thyagarajan D, Shanske S, Vazquez-Memije M, De Vivo D, DiMauro S. A novel mitochondrial ATPase 6 point mutation in familial bilateral striatal necrosis. Ann Neurol 1995 38 : 468 72.
111. Carrozzo R, Tessa A, Vazquez-Memije ME et al. The T9176G mtDNA mutation severely affects ATP production and results in Leigh syndrome. Neurology 2001 56 : 687 90.
112. Hirano M, Silvestri G, Blake DM et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical, biochemical, and genetic features of an autosomal recessive mitochondrial disorder. Neurology 1994 44 : 721 7.
113. Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 1999 283 : 689 92.
114. Spinazzola A, Marti R, Nishino I et al. Altered thymidine metabolism due to defects of thymidine phosphorylase. J Biol Chem 2002 277 : 4128 33.
115. Van Goethem G, Schwartz M, Lofgren A, Dermaut B, Van Broeckhoven C, Vissing J. Novel POLG mutations in progressive external ophthalmoplegia mimicking mitochondrial neurogastrointestinal encephalomyopathy. Eur J Hum Genet 2003 11 : 547 9.
116. Yavuz H, Ozel A, Christensen M et al. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis. Arch Neurol 2007 64 : 435 8.
117. Hirano M, Marti R, Casali C et al. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE. Neurology 2006 67 : 1458 60.
118. Zeviani M, Sevidei S, Gallera C et al. An autosomal dominant disorder with multiple deletions of mitochondrial DNA starting in the D-loop region. Nature 1989 339 : 309 11.
119. Bohlega S, Tanji K, Santorelli FM, Hirano M, al-Jishi A, DiMauro S. Multiple mitochondrial DNA deletions associated with autosomal recessive ophthalmoplegia and severe cardiomyopathy. Neurology 1996 46 : 1329 34.
120. Agostino A, Valletta L, Chinnery PF et al. Mutations of ANT1, Twinkle, and POLG1 in sporadic progressive external ophthalmoplegia (PEO). Neurology 2003 60 : 1354 6.
121. Longley MJ, Clark S, Yu Wai Man C et al. Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am J Hum Genet 2006 78 : 1026 34.